Literature DB >> 29097338

Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.

Cesira Giordano1, Simona Barnini1, Constantinos Tsioutis2, Monika A Chlebowicz3, Effie V Scoulica4, Achilleas Gikas4, John W Rossen3, Alexander W Friedrich3, Erik Bathoorn5.   

Abstract

mcr-1 has been reported as the first plasmid-encoded gene conferring colistin resistance. In KPC-producing Klebsiella pneumoniae (KPC-KP), however, colistin resistance is rapidly emerging through other mechanisms. Resistance is frequently due to disruption of the mgrB gene by insertion sequences, e.g. ISL3. The aim of this study was to investigate the expansion of mgrB-mutated KPC-KP isolates. In addition, the localisation and targets of ISL3 sequences within the core and accessory genome of common KPC-KP lineages were identified. A total of 29 clinical K. pneumoniae isolates collected from Italian patients were randomly selected. Whole genome sequences were analysed for resistance genes, plasmids and insertion sequences. In addition, 27 colistin-resistant KPC-KP isolates from a previous study from Crete (Greece) were assessed. Clonal expansion of KPC-KP isolates with various mutations in mgrB among all lineages was observed. In two Italian MLST ST512 isolates and eight Greek ST258 isolates, an identical copy of ISL3 was inserted in mgrB nucleotide position 133. ISL3, a transposable restriction-modification system of 8154 nucleotides, was located on pKpQIL-like plasmids and may transpose into the chromosome. In four isolates, chromosomal integration of ISL3 in diverse inner membrane proteins other than mgrB was identified. Colistin resistance is most often explained by clonal expansion of isolates with mutated mgrB. pKpQIL-like plasmids, which are omnipresent in KPC-KP, carry insertion sequences such as ISL3 that have mgrB as a target hotspot for transposition. Transposition of insertion sequences from plasmids and subsequent clonal expansion may contribute to the emerging colistin resistance in KPC-KP.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colistin; ISL3; KPC; Klebsiella pneumoniae; Molecular epidemiology; mgrB

Mesh:

Substances:

Year:  2017        PMID: 29097338     DOI: 10.1016/j.ijantimicag.2017.10.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  13 in total

1.  Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.

Authors:  Nenad Macesic; Brian Nelson; Thomas H Mcconville; Marla J Giddins; Daniel A Green; Stephania Stump; Angela Gomez-Simmonds; Medini K Annavajhala; Anne-Catrin Uhlemann
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

2.  Multifaceted mechanisms of colistin resistance revealed by genomic analysis of multidrug-resistant Klebsiella pneumoniae isolates from individual patients before and after colistin treatment.

Authors:  Yan Zhu; Irene Galani; Ilias Karaiskos; Jing Lu; Su Mon Aye; Jiayuan Huang; Heidi H Yu; Tony Velkov; Helen Giamarellou; Jian Li
Journal:  J Infect       Date:  2019-07-30       Impact factor: 6.072

3.  Molecular Epidemiological Insights into Colistin-Resistant and Carbapenemases-Producing Clinical Klebsiella pneumoniae Isolates.

Authors:  Domiziana Di Tella; Manuela Tamburro; Giuliana Guerrizio; Incoronata Fanelli; Michela Lucia Sammarco; Giancarlo Ripabelli
Journal:  Infect Drug Resist       Date:  2019-12-03       Impact factor: 4.003

4.  Reduced Fitness Costs of mcr-1.2 Compared to Mutated pmrB in Isogenic Colistin-Resistant KPC-3-Producing Klebsiella pneumoniae.

Authors:  Cesira Giordano; Adrian Klak; Simona Barnini; Monika A Chlebowicz; Mariacristina Menconi; John W Rossen; Alexander W Friedrich; Erik Bathoorn
Journal:  mSphere       Date:  2019-11-06       Impact factor: 4.389

Review 5.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

Review 6.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29

7.  Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria.

Authors:  Eman G Youssef; Lina Zhang; Sondus Alkhazraji; Teclegiorgis Gebremariam; Shakti Singh; Nannette Y Yount; Michael R Yeaman; Priya Uppuluri; Ashraf S Ibrahim
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

8.  In vitro activity of ceftazidime/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015-17).

Authors:  Iris Spiliopoulou; Krystyna Kazmierczak; Gregory G Stone
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

9.  Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital.

Authors:  Julian Schwanbeck; Wolfgang Bohne; Ufuk Hasdemir; Uwe Groß; Yvonne Pfeifer; Boyke Bunk; Thomas Riedel; Cathrin Spröer; Jörg Overmann; Hagen Frickmann; Andreas E Zautner
Journal:  Microorganisms       Date:  2021-03-31

10.  Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020.

Authors:  Marco Falcone; Cesira Giordano; Simona Barnini; Giusy Tiseo; Alessandro Leonildi; Paolo Malacarne; Francesco Menichetti; Alessandra Carattoli
Journal:  Euro Surveill       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.